Granuloma Annulare Induced by Adalimumab / 대한피부과학회지
Korean Journal of Dermatology
; : 656-659, 2011.
Article
em Ko
| WPRIM
| ID: wpr-171798
Biblioteca responsável:
WPRO
ABSTRACT
Adalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-alpha) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-alpha is involved, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. As the use of adalimumab is becoming more widespread, cutaneous side effects are being increasingly reported. Various dermatologic adverse events have been reported in the literature, including injection site reactions, psoriasis-like eruption and pityriasis rosea. Herein, we describe a case of GA associated with adalimumab treatment for adult-onset Still's disease, which has not been reported in Korea.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Artrite Reumatoide
/
Espondilite Anquilosante
/
Doença de Crohn
/
Artrite Psoriásica
/
Fator de Necrose Tumoral alfa
/
Doença de Still de Início Tardio
/
Granuloma Anular
/
Pitiríase Rósea
/
Anticorpos Monoclonais Humanizados
/
Adalimumab
Limite:
Humans
País/Região como assunto:
Asia
Idioma:
Ko
Revista:
Korean Journal of Dermatology
Ano de publicação:
2011
Tipo de documento:
Article